Halotag as a reporter gene: Positron emission tomography imaging with 64cu-labeled second generation HaloTag ligands

American Journal of Translational Research

Volumn 5, Issue 3, 2013, Pages 291-302

  Hong, Hao ^a   Benink, Hélène A ^b   Uyeda, H Tetsuo ^c   Valdovinos, Hector F ^d   Zhang, Yin ^d   Meisenheimer, Poncho ^c   Barnhart, Todd E ^d   Fan, Frank ^b   Cai, Weibo ^a,d,e  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b LLC ^*

^c CRP USA LLC   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Cancer; Halotag; Molecular imaging; Positron emission tomography (PET); Reporter gene

Indexed keywords

ANTIBIOTIC G 418; COPPER 64; HALOTAG LIGAND; HALOTAG PROTEIN; HYDROLASE; LIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; FEMALE; GAMMA COUNTER; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; IMMUNOFLUORESCENCE; ISOTOPE LABELING; MASS SPECTROMETRY; MICROSCOPY; MOLECULAR CLONING; MOUSE; NEOPLASM; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POSITRON EMISSION TOMOGRAPHY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOACTIVITY; REPORTER GENE; TUMOR VOLUME; ULTRAVIOLET DETECTOR;

MURINAE;

EID: 84877042847     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Liu DS, Phipps WS, Loh KH, Howarth M and Ting AY. Quantum Dot Targeting with Lipoic Acid Ligase and HaloTag for Single-Molecule Imaging on Living Cells. ACS Nano 2012; 6: 11080-11087.
2. Zhang Y, So MK, Loening AM, Yao H, Gambhir SS and Rao J. HaloTag protein-mediated site specific conjugation of bioluminescent proteins to quantum dots. Angew Chem Int Ed Engl 2006; 45: 4936-4940.
3. Takemoto K, Matsuda T, McDougall M, Klaubert DH, Hasegawa A, Los GV, Wood KV, Miyawaki A and Nagai T. Chromophore-Assisted Light Inactivation of HaloTag Fusion Proteins Labeled with Eosin in Living Cells. ACS Chem Biol 2011; 6: 401-406.
4. Schroder J, Benink H, Dyba M and Los GV. In vivo labeling method using a genetic construct for nanoscale resolution microscopy. Biophys J 2009; 96: L01-03.
5. Kosaka N, Ogawa M, Choyke PL, Karassina N, Corona C, McDougall M, Lynch DT, Hoyt CC, Levenson RM, Los GV and Kobayashi H. In vivo stable tumor-specific painting in various colors using dehalogenase-based protein-tag fluorescent ligands. Bioconjug Chem 2009; 20: 1367-1374.
6. Ohana RF, Hurst R, Vidugiriene J, Slater MR, Wood KV and Urh M. HaloTag-based purification of functional human kinases from mammalian cells. Protein Expr Purif 2011; 76: 154-164.
7. Svendsen S, Zimprich C, McDougall MG, Klaubert DH and Los GV. Spatial separation and bidirectional trafficking of proteins using a multi-functional reporter. BMC Cell Biol 2008; 9: 17.
8. Urh M, Hartzell D, Mendez J, Klaubert DH and Wood K. Methods for detection of protein-protein and protein-DNA interactions using HaloTag. Methods Mol Biol 2008; 421: 191-209.
9. Yamaguchi K, Inoue S, Ohara O and Nagase T. Pulse-chase experiment for the analysis of protein stability in cultured mammalian cells by covalent fluorescent labeling of fusion proteins. Methods Mol Biol 2009; 577: 121-131.
10. Hartzell DD, Trinklein ND, Mendez J, Murphy N, Aldred SF, Wood K and Urh M. A functional analysis of the CREB signaling pathway using HaloCHIP-chip and high throughput reporter assays. BMC Genomics 2009; 10: 497.
11. Taniguchi Y and Kawakami M. Application of HaloTag protein to covalent immobilization of recombinant proteins for single molecule force spectroscopy. Langmuir 2010; 26: 10433-10436.
12. Zhou ZP, Shimizu Y, Tadakuma H, Taguchi H, Ito K and Ueda T. Single molecule imaging of the trans-translation entry process via anchoring of the tagged ribosome. J Biochem 2011; 149: 609-618.
13. Urh M and Rosenberg M. HaloTag, a Platform Technology for Protein Analysis. Curr Chem Genomics 2012; 6: 72-78.
14. Los GV and Wood K. The HaloTag: a novel technology for cell imaging and protein analysis. Methods Mol Biol 2007; 356: 195-208.
15. Los GV, Encell LP, McDougall MG, Hartzell DD, Karassina N, Zimprich C, Wood MG, Learish R, Ohana RF, Urh M, Simpson D, Mendez J, Zimmerman K, Otto P, Vidugiris G, Zhu J, Darzins A, Klaubert DH, Bulleit RF and Wood KV. HaloTag: a novel protein labeling technology for cell imaging and protein analysis. ACS Chem Biol 2008; 3: 373-382.
16. Kang JH and Chung JK. Molecular-genetic imaging based on reporter gene expression. J Nucl Med 2008; 49 Suppl 2: 164S-179S.
17. Jacobs A, Voges J, Reszka R, Lercher M, Gossmann A, Kracht L, Kaestle C, Wagner R, Wienhard K and Heiss WD. Positron-emission to mography of vector-mediated gene expression in gene therapy for gliomas. Lancet 2001; 358: 727-729.
18. 18F-FHBG PET in a patient with glioma. Nat Clin Pract Oncol 2009; 6: 53-58.
19. Giepmans BN, Adams SR, Ellisman MH and Tsien RY. The fluorescent toolbox for assessing protein location and function. Science 2006; 312: 217-224.
20. Contag CH and Bachmann MH. Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 2002; 4: 235-260.
21. Min JJ and Gambhir SS. Molecular imaging of PET reporter gene expression. Handb Exp Pharmacol 2008; 277-303.
22. Gilad AA, Ziv K, McMahon MT, van Zijl PC, Neeman M and Bulte JW. MRI reporter genes. J Nucl Med 2008; 49: 1905-1908.
23. Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002; 2: 683-693.
24. Cai W and Hong H. Peptoid and positron emission tomography: an appealing combination. Am J Nucl Med Mol Imaging 2011; 1: 76-79.
25. 11C-acetate. Am J Nucl Med Mol Imaging 2012; 2: 33-47.
26. Hong H, Benink HA, Zhang Y, Yang Y, Uyeda HT, Engle JW, Severin GW, McDougall MG, Barnhart TE, Klaubert DH, Nickles RJ, Fan F and Cai W. HaloTag: a novel reporter gene for positron emission tomography. Am J Transl Res 2011; 3: 392-403.
27. Zhang Y, Hong H, Engle JW, Yang Y, Barnhart TE and Cai W. Positron emission tomography and near-infrared fluorescence imaging of vascular endothelial growth factor with dual-labeled bevacizumab. Am J Nucl Med Mol Imaging 2012; 2: 1-13.
28. 89Zr and IRDye 800CW. Am J Transl Res 2012; 4: 333-346.
29. Hong H, Yang Y, Zhang Y, Engle JW, Barnhart TE, Nickles RJ, Leigh BR and Cai W. Positron emission tomography imaging of CD105 expression during tumor angiogenesis. Eur J Nucl Med Mol Imaging 2011; 38: 1335-1343.
30. 18F-based radiotracers. Am J Nucl Med Mol Imaging 2012; 2: 55-76.
31. Nolting DD, Nickels ML, Guo N and Pham W. Molecular imaging probe development: a chemistry perspective. Am J Nucl Med Mol Imaging 2012; 2: 273-306.
32. Ray P, Tsien R and Gambhir SS. Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects. Cancer Res 2007; 67: 3085-3093.
33. James ML and Gambhir SS. A molecular imaging primer: modalities, imaging agents, and applications. Physiol Rev 2012; 92: 897-965.
34. Balyasnikova S, Lofgren J, de Nijs R, Zamogilnaya Y, Hojgaard L and Fischer BM. PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging. Am J Nucl Med Mol Imaging 2012; 2: 458-474.
35. Temma T and Saji H. Radiolabelled probes for imaging of atherosclerotic plaques. Am J Nucl Med Mol Imaging 2012; 2: 432-447.
36. Zeman MN and Scott PJ. Current imaging strategies in rheumatoid arthritis. Am J Nucl Med Mol Imaging 2012; 2: 174-220.
37. Hong H, Yang Y, Zhang Y and Cai W. Non-invasive imaging of human embryonic stem cells. Curr Pharm Biotechnol 2010; 11: 685-692.
38. Hong H, Yang Y, Zhang Y and Cai W. Non-invasive cell tracking in cancer and cancer therapy. Curr Top Med Chem 2010; 10: 1237-1248.
39. Cai W, Zhang Y and Kamp TJ. Imaging of induced pluripotent stem cells: from cellular reprogramming to transplantation. Am J Nucl Med Mol Imaging 2011; 1: 18-28.